Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carmell Co. stock logo
CTCX
Carmell
$2.44
+0.8%
$2.09
$0.17
$1.98
$51.01M0.514.32 million shs10,621 shs
GBS Inc. stock logo
GBS
GBS
$1.78
-2.7%
$1.52
$0.36
$2.89
$26.50M1.32955,325 shs508,618 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.22
-0.9%
$2.43
$1.99
$3.80
$68.01M0.5767,358 shs212,000 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.28
-1.7%
$0.28
$0.03
$1.00
$31.93M1.2674,785 shs6,027 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carmell Co. stock logo
CTCX
Carmell
0.00%-5.79%-17.01%+1,973.07%+46.11%
GBS Inc. stock logo
GBS
GBS
0.00%+16.34%+11.25%+31.85%-2.73%
InspireMD, Inc. stock logo
NSPR
InspireMD
0.00%-1.53%-9.80%-12.93%-5.65%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00%-2.10%0.00%-23.54%+600.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Carmell Co. stock logo
CTCX
Carmell
N/AN/AN/AN/AN/AN/AN/AN/A
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
3.383 of 5 stars
3.54.00.00.02.72.50.6
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carmell Co. stock logo
CTCX
Carmell
0.00
N/AN/AN/A
GBS Inc. stock logo
GBS
GBS
0.00
N/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50102.70% Upside
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest GBS, NSPR, CTCX, and TMDIF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carmell Co. stock logo
CTCX
Carmell
$32.84K1,553.28N/AN/A$1.07 per share2.28
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/A$0.44 per shareN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M9.68N/AN/A$1.83 per share1.21
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$17.63M1.81$14.00 per share0.02$1.05 per share0.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carmell Co. stock logo
CTCX
Carmell
-$15.44MN/A0.00N/AN/A-217.50%-50.22%N/A
GBS Inc. stock logo
GBS
GBS
-$8.31M-$0.56N/AN/AN/AN/A-85.64%-54.42%N/A
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$6.95M$0.05N/AN/AN/A-82.31%-51.47%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Carmell Co. stock logo
CTCX
Carmell
N/AN/AN/AN/AN/A
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carmell Co. stock logo
CTCX
Carmell
N/A
0.31
0.29
GBS Inc. stock logo
GBS
GBS
N/A
2.33
2.33
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/A
3.73
3.73

Institutional Ownership

CompanyInstitutional Ownership
Carmell Co. stock logo
CTCX
Carmell
24.22%
GBS Inc. stock logo
GBS
GBS
2.79%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.03%

Insider Ownership

CompanyInsider Ownership
Carmell Co. stock logo
CTCX
Carmell
29.00%
GBS Inc. stock logo
GBS
GBS
0.27%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.02%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carmell Co. stock logo
CTCX
Carmell
1420.91 million14.84 millionNot Optionable
GBS Inc. stock logo
GBS
GBS
714.89 million14.85 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Titan Medical Inc. stock logo
TMDIF
Titan Medical
50114.04 million4.56 millionNot Optionable

Recent News About These Companies

Titan Announces Resignations of Directors
Proxy Deadline Thursday September 26, 2024
Titan Announces Q&A Session with Shareholders
Titan Medical | Morning Blend
Titan Medical Inc. (QTNA.SG)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Carmell stock logo

Carmell NASDAQ:CTCX

$2.44 +0.02 (+0.83%)
As of 07/3/2025

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

GBS stock logo

GBS NYSE:GBS

$1.78 -0.05 (-2.73%)
As of 07/3/2025

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.22 -0.02 (-0.89%)
Closing price 04:00 PM Eastern
Extended Trading
$2.16 -0.06 (-2.48%)
As of 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Titan Medical stock logo

Titan Medical NASDAQ:TMDIF

$0.28 0.00 (-1.69%)
As of 07/3/2025

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.